CGEN FY 2018 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$215M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M

Gross Profit

$17M94.2% margin

Operating Income

-$23M-130.5% margin

Net Income

-$23M-127.0% margin

EPS (Diluted)

$-0.41

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$53M

Total Liabilities

$16M

Stockholders' Equity

$37M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$0	—
Gross Profit	$17M	-$2M	+1152.5%
Operating Income	-$23M	-$37M	+37.9%
Net Income	-$23M	-$37M	+39.0%